회원가입 | 연락처 | 사이트맵 | English

      회사소개 | 리포트 | 커스텀 리서치 | 고객지원


로그인

카테고리

유/무선통신

전기/전자

디지털기기/미디어/방송

Information Technology

에너지

생명공학

화학/신소재

자동차

환경

일반소비재

마케팅/광고

금융

건설

교통/운송

소비자조사

방위/항공/우주

식음료

중공업

교육

기계

무역

스포츠/레저

해운/조선

패션

정부/정책

공예/귀금속

컴퍼니 프로파일

기타산업

 
현재위치 : HOME > 리포트 > 생명공학 > 제약
The World Dermatological Market Outlook 2010-2024
발행사 Visiongain

발행일 2009-11
분량 142 pages
서비스형태 Report
판매가격

인쇄하기
– where will the main commercial opportunities lie in the treatment of skin disorders? Our new pharma market report explains

The dermatological drug market continues to be important and competitive globally. New treatments for skin disorders and increasing disease prevalence will lead to further expansion of that market area, we predict. There are potential gains in all the main aspects of pharma development: novel drugs, drug delivery innovation, generics and biotechnology. Our brand new report - The World Dermatological Market Outlook 2010-2024 - explains why that market will expand, revealing where the most-exciting developments will lie during our forecast period. And how you can benefit from this expansion.

In particular, this study examines markets for treating the following skin disorders:
• Dermatitis
• Skin infections
• Acne
• Psoriasis.

Also covered are the following dermatological conditions:
• Alopecia
• Rosacea.

What types of therapeutic agent are likely to enter the market from 2010 onwards, and will they hold the potential to dominate this market area? Where will the best commercial opportunities in skin disorders lie from 2010 onwards? What are the most-crucial drivers and restraints in the global dermatological market? This report will provide you with the information that you need to understand current trends and future directions in pharmacological dermatology. In particular, we discuss commercial prospects for the following products in detail, from the present forward:

• Medrol
• Celestone
• Protopic
• Elocon
• Aldara
• Zovirax
• Lamisil
• Solodyn
• Differin
• BenzaClin
• Diane
• Daivobet
• Taclonex
• Dovonex
• Propecia
• Doryx
• Surgicel

Comprehensive analysis of the global dermatology market

The World Dermatological Market Outlook 2010-2024 critically examines that sector through a comprehensive review of primary and secondary information sources. Our new report provides detailed sales forecasts, market share analyses, discussions of pipeline developments and analyses of commercial drivers and restraints, including a SWOT analysis. There are over 100 tables and figures included, as well as two full interviews with relevant experts. The result is a comprehensive market- and industry-centred study, with detailed analyses and informed opinion to benefit your work.

Why you should buy The World Dermatological Market Outlook 2010-2024

In this report, you will receive the following benefits in particular:
• You will assess the current market for dermatological drugs
• You will review the overall dermatological market, including a global sales forecast
• You will receive sales forecasts for the main dermatological submarkets, with detailed discussions
• You will receive sales forecasts for the leading products in those submarkets with discussions of market potential and competition
• You will receive sales forecasts for leading geographical markets, with informed discussion
• You will examine commercial drivers and restraints in depth
• You will discover the most-exciting pipeline developments in the sector
• You will discover expert opinions from our original interviews with authorities in industry and academia.

회사소개 | 개인정보보호정책 | 이용약관 | 배송/결제안내 | 이용안내

서울시 강남구 논현동 210-1 삼원빌딩 | 회사명 : (주)엘앤에치
대표전화 : 02-554-0001 / 팩스 : 02-3444-5501 / 이메일 : sales@landh.co.kr
Copyright ⓒ 2008 LNH, Inc. All rights reserved.